Janiczek Wealth Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Janiczek Wealth Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5	Closed	-$1.58K	–	1173
2023 Q4	$1.58K	Buy	+5	New	+$972	﹤0.01%	878

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Janiczek Wealth Management's KRTX Position: Q1 2024 in Review

Janiczek Wealth Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 5 shares — an estimated $1.58K sold.

Janiczek Wealth Management first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $1.58K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Janiczek Wealth Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Janiczek Wealth Management sold 5 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.58K.
Janiczek Wealth Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Janiczek Wealth Management's Karuna Therapeutics, Inc. Common Stock position peaked at $1.58K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Janiczek Wealth Management's 13F filing for Q1 2024, filed 15 Apr 2024.